How organ-on-a-chip technologies are revolutionizing drug discovery and development – Mark Rutledge
Summary
Mark Rutledge, CEO of World Precision Instruments (WPI), discusses the company’s journey and strategic direction in the life sciences and diagnostics space. He highlights the importance of focus and direction in driving growth and shares how WPI has transitioned from a lab supply and surgical tools company to an innovative cellular analysis and cell biology company. Mark also explains the potential of organ-on-a-chip technology in drug discovery and development, emphasizing the need for accuracy and standardization in the field. He discusses WPI’s differentiation in the tier instrumentation market and the value of partnerships and collaborations. Rutledge concludes by discussing the future of pharmaceutical development and the role of technology in driving cost-effectiveness and faster time-to-market for therapies.
Takeaways
WPI has transitioned from a lab supply and surgical tools company to an innovative cellular analysis and cell biology company. Organ-on-a-chip technology has the potential to revolutionize drug discovery and development by providing more accurate and standardized models for testing. WPI differentiates itself in the tier instrumentation market through automation, speed, and user-friendly interfaces. Partnerships and collaborations play a crucial role in expanding WPI’s capabilities and driving innovation in the field. The future of pharmaceutical development lies in leveraging technology to drive cost-effectiveness, faster time-to-market, and more predictable outcomes for patients.
Chapters
00:00 Introduction and Background
03:44 Joining WPI and Setting the Direction
09:09 Private Equity Ownership and Strategy
12:29 Expanding into Cell Biology and Organ-on-a-Chip
14:34 The Growth of Organ-on-a-Chip
25:08 Partnerships and Collaborations
29:08 Quality Control of Stem Cells
30:47 Software and User Interface Improvements
33:01 Potential for AI Integration
35:27 Future of Pharmaceutical Development
37:38 Advancements in Technology and Impact on Drug Discovery
38:51 Closing Remarks
Note: This article is a summary of the podcast episode “Interview with Mark Rutledge:How organ-on-a-chip technologies are revolutionizing drug discovery and development” hosted by Jeremy Derosier. For the full interview, please listen to the podcast episode linked above.
Thanks for your support
Produced by
All rights reserved. Modern LifeScience